How to read a peptide certificate of analysis

Start at the bottom: does the lot number match?

Before reading a single result, find the lot or batch number on the certificate and compare it to the number printed on the vial. If they differ, the document describes a different batch of material and nothing else on it applies to what you have.

This is the most common failure in the category and the easiest to check. A vendor who publishes one certificate per compound rather than one per lot is publishing a marketing asset, not a test result.

Identity: is it the molecule on the label?

Identity is normally established by mass spectrometry. The certificate should report an observed mass and an expected mass for the sequence, and they should agree within the instrument's tolerance.

A certificate that reports purity but never establishes identity has answered the easier of the two questions. Ninety-nine percent pure something is not a useful statement.

Purity: the number and the trace

Purity is normally reported as area percent by reverse-phase HPLC. The number alone is an assertion. The chromatogram is the result.

• Look for the main peak and its retention time.
• Look at what is beside it. Closely-eluting related substances are normal in peptide synthesis, particularly for longer or modified sequences.
• Check the integration. A trace where the baseline has been drawn generously can move a number a full percentage point.
• Check the method: column, gradient, detection wavelength. A purity figure without a method is not reproducible.

Net peptide content: the number that changes the price

Lyophilized peptide is not one hundred percent peptide. It carries counter-ions - trifluoroacetate is common - plus residual water. Net peptide content, sometimes reported by amino acid analysis or nitrogen determination, tells you how much of the vial mass is actually the sequence.

Vendors differ in whether the labeled milligrams are gross or net. That difference can be ten to twenty percent, which is larger than most of the price gaps people argue about. It is a fair question to ask before comparing two prices per milligram.

Who ran the test?

A certificate should name the laboratory, carry a report date and be verifiable with that laboratory rather than only with the vendor who is selling you the vial. Third-party means the testing organization has no commercial interest in the result.

An in-house certificate is not worthless - a manufacturer testing its own output is normal practice - but it is a different kind of evidence and should be labeled as what it is.

Four certificates that are true and still useless

1. Right compound, wrong lot. Every result is real and none of it describes your vial.
2. Purity without identity. Very pure, unspecified.
3. A number without a trace. No chromatogram, no method, no way to check the integration.
4. An image of a document with no issuing laboratory named. Unverifiable by construction.

What Effect commits to

Current supply-record summaries of purity and measured mass, visible without an account. The full source report, chromatogram and access details stay private.

A product-and-size summary does not prove that the identifier on a shipped vial matches the tested material. The private fulfillment check must establish that match. Earlier sample results are kept separate from current supply records.

First decide what kind of document you are reading

Certificate of analysis can describe several different records. It may be a manufacturer's release certificate, a third-party sample report, a retest, or a public summary derived from a longer private report. Those documents can all contain valid numbers while supporting different claims.

A lot-release certificate should connect the test sample to saleable inventory. A historical sample report says something only about the submitted sample. A public summary says only what its displayed fields say. Before checking the percentage, read the scope label and ask whether the document claims to cover the lot being offered.

Effect's initial public testing table is intentionally the third kind: a limited summary of owner-supplied historical third-party samples. It is not labeled as an Effect lot certificate and it does not replace the lot-matched testing required before inventory is sold.

Identity, composition and quantity are three separate questions

Identity asks whether the principal material is consistent with the intended molecule. For peptides, mass spectrometry is commonly part of that answer. The report should give enough context to compare observed and expected species; a bare pass statement hides the comparison.

Composition asks what share of detected chromatographic area is assigned to the principal component under the stated HPLC method. This is the familiar purity percentage. It does not establish the number of milligrams in the vial, and it does not by itself establish molecular identity.

Quantity asks how much material or target analyte the chosen method measured. That result must state its basis. Gross powder mass, peptide-equivalent content and an assay result are not automatically the same number. A useful table labels measured mass rather than inviting the reader to infer it from purity.

Precision is not the same thing as certainty

A report may display two or three decimal places because the instrument software calculated them. Those decimal places do not erase sampling error, calibration, recovery, integration judgment or method uncertainty. Display precision and measurement confidence are related, but they are not synonyms.

When comparing results, do not rank 99.61% as categorically superior to 99.56% without the methods and their variability. The practical reading is that both are reported values under their own methods. A meaningful acceptance decision comes from a written specification, not from sorting a spreadsheet by the last decimal.

Rounding should also be consistent. Public summaries should reproduce the laboratory's reported precision rather than adding digits the source did not provide or rounding in a direction that makes the result look more favorable.

Read the chromatogram as a record, not decoration

The chromatogram shows detector response across retention time. The peak table shows which regions were integrated and how area was assigned. Read them together. A clean-looking image without an integration table can conceal which peaks were excluded or combined.

Method details define the measurement: column chemistry, mobile phases, gradient, flow, temperature and detection wavelength can change separation. Two laboratories can test the same material under different methods and produce values that should not be compared as though everything else were equal.

Baseline selection and integration thresholds matter most where small related peaks sit near the principal component. The right question is not whether the trace looks dramatic. It is whether the method, trace and table form a reproducible account of the reported number.

Lot linkage is a chain of custody

A matching printed lot number is necessary, but the internal record should go further. It should show who selected the sample, when it left controlled inventory, how the laboratory identified it, when the result was received and which inventory decision followed.

That chain reduces two common errors: attaching a good report to a later batch with the same product name, and publishing a supplier's sample report as if Effect commissioned it for Effect inventory. Both errors can occur without falsifying a single test value.

A retained sample can support investigation if a later question arises. The retention record should use the same lot and sample identifiers as the certificate so another person can reconstruct the chain without relying on memory.

Public redaction and private verification can coexist

Some source reports contain QR codes, access codes, report identifiers, signatures, client details or verification links. Publishing those elements can enable unauthorized reuse of an expensive report. A site may therefore publish a restrained result summary while keeping the complete document in a controlled internal record.

Redaction must not become selective storytelling. The public summary should identify its scope, reproduce the displayed results accurately and avoid implying independent verification that the public cannot perform. Internally, the unredacted report should remain available for release review and counsel or laboratory follow-up.

Effect's public summary rule is deliberately narrow: product, labeled mass, measured mass and reported purity. It excludes report numbers, lot codes, QR codes, access credentials, signatures, analyst identities, verification addresses and client information.

A repeatable review sequence

1. Read the scope statement: lot release, historical sample, retest or public summary.
2. Match the defined molecule, including sequence form and modifications, to the specification.
3. Check the sample and lot trail before interpreting any result.
4. Read identity, chromatographic composition and measured quantity as separate findings.
5. Check methods, units, precision, dates and reviewer decision in the private record.
6. Publish only the fields allowed by the disclosure policy, without broadening the claim.

Following the same order every time is more reliable than beginning with the largest number on the page. It also makes differences between reports easier to spot.

Frequently asked